| Parameter | Target | Achieved |
| Incidence decline (compared with 2015 baseline) | 20% | 11% |
| Deaths decline (compared with 2015 baseline) | 35% | 9.2% |
| Catastrophic costs incurred by individuals with TB/their families | 0 | 47% |
| People treated for TB, 2018-2022 | 40 million | 19.8 million (50%) |
| Children treated for TB, 2018-2022 | 3.5 million | 1.4 million (41%) |
| People with MDR TB treated, 2018-2022 | 1.5 million | 483,000 (32%0 |
| Children with MDR TB treated, 2018-2022 | 115,000 | 12,200 (11%) |
| People treated for LTBI, 2018-2022 | 30 million | 8.7 million (29%) |
| People living with HIV treated for LTBI, 2018-2022 | 6 million | 7.2 million (>100%) |
| Household contacts < 5 years treated for LTBI, 2018-2022 | 4 million | 1.2 million (29%) |
| Household contacts > 5 years treated for LTBI, 2018-2022 | 20 million | 0.32 million (1.6%) |
| Annual funding needs | 13 billion USD | 5.3 billion USD |
| Annual Research funding for TB | 2 billion USD | 901 million USD |